Xi 'an's IVF technology has not been fully incorporated into medical insurance. According to the regulations of Xi Medical Insurance Bureau, the medical insurance fund can only pay the fees when some specific infertile patients receive assisted reproductive technology treatment.
Xi 'an specifically stipulates that the Catalogue of National and Shaanxi Basic Medical Insurance Diagnosis and Treatment Projects includes some projects of assisted reproductive technology such as in vitro fertilization and embryo culture, and the expenses of these projects can be paid by the medical insurance fund. However, if it is just a simple IVF technology, it is not within the scope of reimbursement.
IVF is a common name of in vitro fertilization-embryo transfer technology, which refers to a baby born by artificially fertilizing eggs and sperm in vitro, developing into early embryos, and then transplanting them into the mother's uterus for development. At first, Patrick steptoe, a British obstetrician, and Edwards, a physiologist, made a successful study on this. This technology has caused a sensation in the world scientific community. 1978 On July 25th, the world's first test-tube baby was born in Britain. 20 1 1 The first IVF with intracytoplasmic sperm injection in China was born in Peking University Third Hospital, and the first IVF with cryopreserved oocytes was born in China on 20 14.
IVF is an assisted reproductive technology, which is suitable for infertile patients caused by various reasons. In the process of IVF, the doctor will take out the patient's eggs and sperm for fertilization and culture in the laboratory. The cultured embryos will be observed and evaluated for a period of time, and then the best quality embryos will be selected and transplanted into the mother's uterus. If the transfer is successful, the embryo will continue to develop into a healthy baby.
IVF technology includes in vitro fertilization-embryo transfer, intracytoplasmic sperm microinjection, preimplantation gene diagnosis and many other technologies. Among them, in vitro fertilization-embryo transfer technology is the most basic technology and one of the most widely used technologies. This technique is suitable for infertility caused by female factors, such as tubal obstruction, endometriosis, ovulation disorder and so on. However, intracytoplasmic sperm microinjection is suitable for male infertility, such as severe oligozoospermia, asthenospermia and azoospermia. Pre-implantation gene diagnosis technology can detect the genes of embryos before embryo transfer and eliminate the risk of some genetic diseases.
It should be noted that IVF technology is not omnipotent, and its success rate is affected by many factors, such as the patient's age, the cause of infertility, the quality of eggs and sperm. At the same time, IVF technology also has certain risks and complications, such as multiple pregnancy and ovarian hyperstimulation syndrome. Therefore, patients need to undergo a comprehensive physical examination and evaluation before receiving IVF treatment, and they should be treated under the guidance of professional doctors.
To sum up:
In Xi, IVF technology has not been fully incorporated into medical insurance. Only the expenses incurred by some specific infertility patients receiving assisted reproductive technology treatment can be paid by the medical insurance fund. For the simple IVF technology, patients need to bear the related expenses themselves.
Legal basis:
Article 24 of the Social Insurance Law of People's Republic of China (PRC) stipulates: "The state establishes and improves the new rural cooperative medical system. The management measures for the new rural cooperative medical system are formulated by the State Council. "